Home » Topics » BioWorld Science

BioWorld Science
RSS

Abbisko Therapeutics synthesizes new FGFR2/FGFR3 inhibitors

March 23, 2022

Cullgen discovers new PROTACs

March 23, 2022

NALO Therapeutics identifies new c-Myc and/or N-myc degradation inducers

March 23, 2022

Kumquat Biosciences patents new GTPase KRAS inhibitors

March 23, 2022

Gasherbrum Bio discloses GLP-1 receptor agonists

March 23, 2022

Novel CD56-targeting MMAE-conjugated antibody shows efficacy in models of MCC

March 23, 2022

New Merck & Co. LRRK2 inhibitors show good drug properties for treating Parkinson's disease

March 23, 2022

Blockade of retinoic acid receptor ameliorates vision loss in preclinical retinal degeneration

March 23, 2022

Sosei Heptares presents preclinical data on SST5 receptor agonist HTL-0030310

March 23, 2022

AU-007 shows promising anticancer activity in murine models

March 22, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...